Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...
Cancer cases reach record level as UK population ages - Cancer Research UK warned that NHS services are struggling to cope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results